Douglas A. Schober
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Neuroscience and Neuropharmacology Research, Ion channel regulation and function, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → Cloning of a Human Receptor of the NPY Receptor Family with High Affinity for Pancreatic Polypeptide and Peptide YY(1995)317 cited
- → Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses(1999)189 cited
- → Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain(1991)172 cited
- → Identification of a high-affinity binding site involved in the transport of endocannabinoids(2005)163 cited
- → Synthesis and Evaluation of a Series of Novel 2-[(4-Chlorophenoxy)methyl]- benzimidazoles as Selective Neuropeptide Y Y1 Receptor Antagonists(1998)152 cited
- → Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats(2002)141 cited
- → Expression cloning of a human brain neuropeptide Y Y2 receptor(1996)140 cited
- → Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala(2002)125 cited
- → The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor.(1996)109 cited
- → M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine(2014)95 cited